Preclinical Safety and Translational Development — Evotec

At Evotec, we approach preclinical safety and translational development as a decision-focused engagement, not a disconnected list of tasks. Before work begins, we clarify the scientific or operational question, the materials and information already available, the constraints that could affect execution, and the evidence your team needs at the end. That alignment lets us build a practical scope for preclinical safety and translational development while keeping the work connected to the broader program.

Our preclinical safety and translational development capabilities

We combine translational science, ADME/DMPK, safety assessment, and development planning to build evidence around candidate readiness. Programs can connect exposure, pharmacology, biomarkers, toxicology, formulation, and manufacturing considerations before clinical entry. The workplan is tailored to the molecule, route, indication, regulatory path, and risk questions that must be resolved. A fit for sponsors seeking an integrated path from candidate selection toward IND-enabling development. This work sits within our Pre-Clinical Research capabilities and is coordinated with the wider program context when the scope requires it.

• A scope for preclinical safety and translational development tied to the program objective
• Defined inputs, responsibilities, review points, and decision criteria
• Deliverables organized for scientific and operational follow-through

How we shape the scope

A strong scope makes the work easier to execute and easier to evaluate. We document the core question, required inputs, proposed activities, review points, and expected outputs, then connect each element to a program need. Where multiple approaches could be reasonable, we explain the tradeoffs and agree how the choice will be made. That discipline helps protect timelines while giving the technical team room to respond to the evidence.

Working with Evotec

Our team treats communication as part of the technical service. We establish contacts, review points, and escalation paths at the outset, then use them to keep decisions moving. Interim conversations distinguish confirmed findings from working interpretations and unresolved questions. That separation is important: it lets the program team act with appropriate confidence while giving specialists space to investigate observations that require more context.

Deliverables built for the next decision

Outputs are planned for the people who will use them next. At kickoff, we agree on the required files, summaries, documentation, and review process rather than assuming a standard package will fit every program. Our final review connects the deliverables back to the original objective and highlights material observations, limitations within the performed scope, and follow-up questions. This makes the handoff more useful for internal review, partner discussions, and subsequent development planning.

Before execution, we also confirm how the work will connect with adjacent activities and which handoffs could affect quality, timing, or interpretation. That check helps us identify missing inputs early, avoid duplicated effort, and keep the completed package consistent with the program's immediate priorities. We record the decisions made during this alignment so the project team has a stable reference as work progresses.

Planning your preclinical safety and translational development project with Evotec

When you are ready to discuss preclinical safety and translational development, bring the objective, development context, available inputs, timing needs, and any fixed technical or quality requirements. Our team will translate those details into a proposed scope with clear responsibilities, review gates, deliverables, assumptions, and dependencies so both sides can assess fit before the work begins.